Evidence map›Paper›PMID 24597531›Full record

ArticleBiomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals2014

Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans.

Mitchell R McGill, Mengde Cao, Archie Svetlov, Matthew R Sharpe, C David Williams, Steven C Curry, Anwar Farhood, Hartmut Jaeschke, Stanislav I Svetlov

Open access · greenAbstract read
In one paragraph

Article in Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Biomarkers of Hepatic Toxicity: An Overview.Current therapeutic research, clinical and experimental · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Identification of Serum Biomarkers to Distinguish Hazardous and Benign Aminotransferase Elevations.Toxicological sciences : an official journal of the Society of Toxicology · 2020
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Inflammasome activation and function in liver disease.Nature reviews. Gastroenterology & hepatology · 2015
    Review
  15. Article
  16. Review
  17. Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients.Toxicological sciences : an official journal of the Society of Toxicology · 2014
    Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Mitchell R McGillDepartment of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center , Kansas City, KS , USA .
Mengde Cao
Archie Svetlov
Matthew R Sharpe
C David Williams
Steven C Curry
Anwar Farhood
Hartmut Jaeschke
Stanislav I Svetlov
University of Kansas Medical Center · USUniversity of Florida · USBanyan Biomarkers (United States) · USGood Samaritan Medical Center · USSt David's Medical Center · USThe University of Kansas Health System · US

Funding

THE ROLE OF HUMAN PXR IN ANTI-TUBERCULOSIS DRUG-INDUCED LIVER INJURYP20RR021940 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLASSEN, CURTIS D · 2006 to 2011
$12.1M
Nuclear Receptors in Liver Health and DiseaseP20GM103549 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2012 to 2015
$8.1M
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007079 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HAGENBUCH, BRUNO · 1985 to 2015
$4.1M
NEUTROPHIL-INDUCED LIVER INJURY TOXICITYR01AA012916 · NIAAA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2001 to 2012
$2.9M
Mitochondrial Dysfunction and Drug HepatotoxicityR01DK070195 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2005 to 2010
$1.8M
Novel diagnostic and safety biomarkers of liver injury and hepatotoxicityR44DK074205 · NIDDK · BANYAN BIOMARKERS, INC. · PI SVETLOV, STANISLAV I · 2008 to 2010
$814k
NCRR NIH HHS 5P20RR021940-07NCRR NIH HHS P20 RR021940NIAAA NIH HHS R01 AA012916NIAAA NIH HHS R01 AA12916NIDDK NIH HHS R01 DK070195NIDDK NIH HHS R44 DK074205NIEHS NIH HHS T32 ES007079NIEHS NIH HHS T32 ES007079-26A2NIGMS NIH HHS 8 P20GM103549-07NIGMS NIH HHS P20 GM103549NIGMS NIH HHS P20 GM12345
6 · The paper itself

Abstract

contextNew biomarkers are needed in acetaminophen (APAP) hepatotoxicity. Plasma argininosuccinate synthetase (ASS) is a promising candidate.

objectiveCharacterize ASS in APAP hepatotoxicity.

methodsASS was measured in plasma from rodents and humans with APAP hepatotoxicity.

resultsIn mice, ASS increased before injury, peaked before alanine aminotransferase (ALT) and decreased rapidly. Fischer rats had a greater increase in ASS relative to ALT. Patients with abnormal liver test results had very high ASS compared to controls. ASS appeared to increase early in some patients, and declined rapidly in all.

conclusionsASS may be a useful biomarker of acute cell death in APAP hepatotoxicity.

Indexed as

AcetaminophenAnimalsArgininosuccinate SynthaseDrug OverdoseHumansMiceMice, Inbred C57BLAcetaminophenArgininosuccinate Synthase

Identifiers

PMID24597531
PMCPMC4280854
OpenAlexW1964157909

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.